Titlebook: Lymphohaematopoietic Growth Factors in Cancer Therapy; Roland Mertelsmann Conference proceedings 1990 Springer-Verlag Berlin Heidelberg 19

Baleful

书目名称Lymphohaematopoietic Growth Factors in Cancer Therapy影响因子(影响力)




书目名称Lymphohaematopoietic Growth Factors in Cancer Therapy影响因子(影响力)学科排名




书目名称Lymphohaematopoietic Growth Factors in Cancer Therapy网络公开度




书目名称Lymphohaematopoietic Growth Factors in Cancer Therapy网络公开度学科排名




书目名称Lymphohaematopoietic Growth Factors in Cancer Therapy被引频次




书目名称Lymphohaematopoietic Growth Factors in Cancer Therapy被引频次学科排名




书目名称Lymphohaematopoietic Growth Factors in Cancer Therapy年度引用




书目名称Lymphohaematopoietic Growth Factors in Cancer Therapy年度引用学科排名




书目名称Lymphohaematopoietic Growth Factors in Cancer Therapy读者反馈




书目名称Lymphohaematopoietic Growth Factors in Cancer Therapy读者反馈学科排名

SEVER

使绝缘

F. M. Rosenthal,A. Lindemann,F. Herrmann,R. Mertelsmann families, interests, and cultural backgrounds shaped their Research in social education over the last forty years has broken new ground in such areas as historical understanding, civic education, cultural studies, and curriculum and assessment.This collection is comprised of reflections on the prof

modest

Melodrama

鞭打

Characteristics of LAK Cells and their use in Adoptive Therapy of Cancer in Experimental Animals,rative effect of IL2 on NK cells has been shown to be dependent on an interaction of the lymphokine with receptors for IL2, as detected by anti-Tac monoclonal antibodies [1]. Proliferating LGL have been shown to express Tac and anti-Tac completely interfered with the growth of the cells and their ma

Medley

Interleukin 2: In Vivo Induction of Effector Cells,evotes great care to their induction, coordination and modulation. The intricacy of regulatory manoeuvres is thus a dominant feature of the immune system [1]. Complex cell-cell communications are required to govern multicellular events. One cell communication code is made by the network of receptor

裂口

事先无准备

套索

Interleukin 2 and LAK Cells,roaches to cancer treatment. One of these is adoptive immunotherapy, defined as the transfer of active cells with antitumour activity to a tumour-bearing host, in order to mediate a therapeutic effect [1–2].